US pharma threats: Donald Trump says ‘very high tariff’ for drug companies by the end of month; semiconductors to follow soon

President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies. These actions, under Section 232, aim to bolster US production, citing national security concerns due to high import volumes. The pharmaceutical tariffs could significantly impact major drugmakers, while semiconductor tariffs may affect tech giants and consumer prices.